These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17725517)

  • 21. Inflammation in ischaemic brain injury: current advances and future perspectives.
    Xia W; Han J; Huang G; Ying W
    Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):253-8. PubMed ID: 19719754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells.
    Jin R; Yang G; Li G
    J Leukoc Biol; 2010 May; 87(5):779-89. PubMed ID: 20130219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain inflammation and adult neurogenesis: the dual role of microglia.
    Ekdahl CT; Kokaia Z; Lindvall O
    Neuroscience; 2009 Feb; 158(3):1021-9. PubMed ID: 18662748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stress primes microglial polarization after global ischemia: Therapeutic potential of progesterone.
    Espinosa-Garcia C; Sayeed I; Yousuf S; Atif F; Sergeeva EG; Neigh GN; Stein DG
    Brain Behav Immun; 2017 Nov; 66():177-192. PubMed ID: 28648389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice.
    Clausen BH; Lambertsen KL; Babcock AA; Holm TH; Dagnaes-Hansen F; Finsen B
    J Neuroinflammation; 2008 Oct; 5():46. PubMed ID: 18947400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia.
    Lehnardt S; Lehmann S; Kaul D; Tschimmel K; Hoffmann O; Cho S; Krueger C; Nitsch R; Meisel A; Weber JR
    J Neuroimmunol; 2007 Oct; 190(1-2):28-33. PubMed ID: 17854911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infiltration of invariant natural killer T cells occur and accelerate brain infarction in permanent ischemic stroke in mice.
    Wang ZK; Xue L; Wang T; Wang XJ; Su ZQ
    Neurosci Lett; 2016 Oct; 633():62-68. PubMed ID: 27637387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain-immune interactions in acute and chronic brain disorders.
    Dirnagl U; Schwab JM
    Neuroscience; 2009 Feb; 158(3):969-71. PubMed ID: 19013503
    [No Abstract]   [Full Text] [Related]  

  • 29. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain.
    Lalancette-Hébert M; Gowing G; Simard A; Weng YC; Kriz J
    J Neurosci; 2007 Mar; 27(10):2596-605. PubMed ID: 17344397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Janus face of inflammation in ischemic brain injury.
    Wang X; Feuerstein GZ
    Acta Neurochir Suppl; 2004; 89():49-54. PubMed ID: 15335100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain activation of monocyte-lineage cells: involvement of interleukin-6.
    Shafer LL; McNulty JA; Young MR
    Neuroimmunomodulation; 2002-2003; 10(5):295-304. PubMed ID: 12759566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic and proteomic microglial profiling: pathways for neuroprotective inflammatory responses following nerve fragment clearance and activation.
    Glanzer JG; Enose Y; Wang T; Kadiu I; Gong N; Rozek W; Liu J; Schlautman JD; Ciborowski PS; Thomas MP; Gendelman HE
    J Neurochem; 2007 Aug; 102(3):627-45. PubMed ID: 17442053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-ischemic administration of diazoxide attenuates long-term microglial activation in the rat brain after permanent carotid artery occlusion.
    Farkas E; Timmer NM; Domoki F; Mihály A; Luiten PG; Bari F
    Neurosci Lett; 2005 Oct; 387(3):168-72. PubMed ID: 16026930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptor signaling in endogenous neuroprotection and stroke.
    Marsh BJ; Williams-Karnesky RL; Stenzel-Poore MP
    Neuroscience; 2009 Feb; 158(3):1007-20. PubMed ID: 18809468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Class I PI3K inhibitor ZSTK474 mediates a shift in microglial/macrophage phenotype and inhibits inflammatory response in mice with cerebral ischemia/reperfusion injury.
    Wang P; He Y; Li D; Han R; Liu G; Kong D; Hao J
    J Neuroinflammation; 2016 Aug; 13(1):192. PubMed ID: 27549161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain activation of monocyte lineage cells: brain-derived soluble factors differentially regulate BV2 microglia and peripheral macrophage immune functions.
    Shafer LL; McNulty JA; Young MR
    Neuroimmunomodulation; 2002-2003; 10(5):283-94. PubMed ID: 12759565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice.
    Che X; Ye W; Panga L; Wu DC; Yang GY
    Brain Res; 2001 Jun; 902(2):171-7. PubMed ID: 11384610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mast cell stabilization limits hypoxic-ischemic brain damage in the immature rat.
    Jin Y; Silverman AJ; Vannucci SJ
    Dev Neurosci; 2007; 29(4-5):373-84. PubMed ID: 17762205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing activation states in microglia.
    Colton C; Wilcock DM
    CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):174-91. PubMed ID: 20205642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TARGETING NEUROINFLAMMATION FOR TREATMENT OF ISCHEMIC STROKE.
    Kokaia Z
    Georgian Med News; 2015 Jun; (243):84-7. PubMed ID: 26087739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.